(Allergan plc)

	AGN latest price $234.1970 (1.56%) ($229.9889 - $236.1370) on Mon. Oct. 10, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.38% (three month average)
RSI	55
Latest Price	$234.1970(1.56%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.8% a day on average for past five trading days.
Weekly Trend	AGN declines -0.4% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(52%)    XLV(50%)    XBI(46%)    ARKG(43%)    SPY(42%)
Factors Impacting AGN price	AGN will decline at least -0.69% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-12%)    IPO(-6%)    SHY(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.69% (StdDev 1.38%)
Hourly BBV	0 ()
Intraday Trend	1.6%

5 Day Moving Average	$229.8(1.91%)
10 Day Moving Average	$228.02(2.71%)
20 Day Moving Average	$230.82(1.46%)
To recent high	-6.8%
To recent low	5.4%
Market Cap	$77.215b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed